1. Home
  2. OXSQ vs SGMO Comparison

OXSQ vs SGMO Comparison

Compare OXSQ & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oxford Square Capital Corp.

OXSQ

Oxford Square Capital Corp.

HOLD

Current Price

$1.78

Market Cap

151.1M

Sector

Finance

ML Signal

HOLD

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.43

Market Cap

155.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OXSQ
SGMO
Founded
2003
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
151.1M
155.1M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
OXSQ
SGMO
Price
$1.78
$0.43
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$4.71
AVG Volume (30 Days)
788.1K
9.1M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
23.46%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,142,565.00
$32,875,000.00
Revenue This Year
N/A
$1.37
Revenue Next Year
$2.27
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.56
$0.38
52 Week High
$2.87
$2.84

Technical Indicators

Market Signals
Indicator
OXSQ
SGMO
Relative Strength Index (RSI) 39.22 40.49
Support Level $1.82 $0.49
Resistance Level $1.87 $0.46
Average True Range (ATR) 0.04 0.03
MACD -0.00 0.00
Stochastic Oscillator 16.83 10.03

Price Performance

Historical Comparison
OXSQ
SGMO

About OXSQ Oxford Square Capital Corp.

Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: